Pradaxa® Injury Lawyers
Houston Defective Drug Attorneys You can Trust
Pradaxa® is a relatively new blood thinner prescribed to prevent stroke in patients suffering from atrial fibrillation. Boehringer Ingelheim promotes Pradaxa® as the superior alternative to Warfarin / Coumadin; however, a recent study showed that patients taking Pradaxa® have a much higher risk of heart attack or severe symptoms of heart disease.
Pradaxa® Study: Higher Heart Attack Risk
Based on data from seven clinical trials, the researchers found that patients who take Pradaxa® have a 33% higher risk of heart attack.
The study concluded that there were serious harmful cardiovascular effects linked to the use of Pradaxa®:
- Myocardial infarction
- Acute coronary syndrome
This study further urged physicians to consider these potential cardiovascular risks when prescribing Pradaxa®. Our firm, Fleming | Nolen | Jez, L.L.P., is proud to represent clients affected by dangerous or defective drugs, including Pradaxa®. If you believe you or a loved one suffered a heart attack or heart disease while using Pradaxa®, contact our firm for a free case evaluation.
FDA Safety Review – Serious Bleeding Risk
On December 8, 2011, the United States Food & Drug Administration (FDA) issued a safety review to investigate a large number of reports of serious internal bleeding and hemorrhaging related to Pradaxa®. The FDA is investigating to determine if serious reports of bleeding and even death are happening more frequently. This investigation will access the serious bleeding risk associated with Pradaxa®.
Schedule Your Free Case Evaluation
Learn more about how we can protect your interests and advocate for you effectively by reaching out to our legal team today.
If you or a loved one has taken Pradaxa® and suffered a heart attack or severe bleeding, contact Fleming | Nolen | Jez, L.L.P. at (866) 977-6671 for a free case consultation by our drug litigation team.